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2I.
INTRODUCTION
In the February 27, 1997 issue of the journal Nature scientists from Scot-
land's Roslin Institute reported their successful eorts to clone an adult sheep
using dierentiated somatic cells from the animal. The clone, named Dolly,
was the rst instance of the successful cloning of an adult mammal. The shock
waves created by the possible ramications of this development were immedi-
ately felt around the world. For the rst time, the cloning of an adult human
being was no longer being considered an impossibility in mainstream scientic
circles. Scientists, governments and laymen around the world were now forced
to began considering the consequences of utilizing this new technology to clone
adult human beings.
Prior to the announcement by Dr. Richard Seed that he would begin
using this technology as an alternative for infertile couples, a temporary morato-
rium on any attempts to clone an adult human being was proposed. While such
a moratorium is generally accepted by most groups, further consensus on how
these activities should be treated remains elusive. Legal, religious, moral and
scientic considerations are intertwined with a complexity found in few other
areas of public concern. Created hastily, most state and federal legislative pro-
posals are criticized as being overly broad and based on uninformed analysis.
In an attempt to develop a more reasoned approach, many in industry
3and academia alike have proposed that regulation of these activities be put in
the hands of some federal agency with more experience in these maters. Early on
in the debate, the Food and Drug Administration (FDA) announced that under
already proposed guidelines it had authority to regulate in this area. Whether
as a temporary or permanent solution, FDA regulation of human cloning was
widely viewed as a moderate and appropriate alternative to pursue. Despite
persistent eorts though, no permanent resolution of this debate has yet been
achieved.
In this paper I will rst describe the science behind this new technique
of cloning, both the methods employed in the process and the resulting uses
of the technology. In part three, I will briey elucidate the major elements in
the debate over how to treat this technology so that we will be able to judge
whether the solutions proposed deal with the concerns mentioned. Part four
deals with the various governmental responses to the use and development of
these techniques. Part ve discuses the FDA's role in regulating this new tech-
nology. This latter section includes a description and analysis of the current
proposal for FDA regulation in this area as well as a model for future legislation
meant to improve upon the current regulatory regime.
II.
THE SCIENCE OF CLONING
A.
4METHODS OF CLONING
Cloning is a technology which has been in use for quite some time. In
agricultural applications it is quit common and \at the molecular and cellular
level, scientists have been cloning human and animal cells and genes for several
decades."1 In general there are three basic types of cloning; molecular (or gene)
and cellular cloning which are not capable of developing into ospring and a
third type which is geared towards reproducing genetically identical animals.2
The rst two types of cloning are the backbone of modern biotechnology and
have proven invaluable in the elds of healthcare and medicine. In addition to
resulting in the development of new vaccines and process's for the production
insulin, these technologies have made gene therapy and the mapping of the
human genome a reality.3 Since they are not capable of producing ospring
however they are only tangentially of concern here.
The third type of cloning can be broken down into two distinct processes;
\blastomere separation" and \nuclear transplantation cloning".4 Blastomere
separation involves the separation of embryonic cells, known as blastomeres,
for use in producing multiple organisms which are genetically identical. Each
blastomere is an undierentiated cell and is totipotent. Totipotency indicates
that each cell has the \total potential" to create an entire organism. The cells
1Cloning Human Beings, Report and Recommendations of the National Bioethics Advisory
Commission (NBAC Report), pg. 14, June 1997.
2Id.
3See, e.g., William S. Klug, Essentials of Genetics 375-383 (1996); T.A. Brown, Gene
Cloning 246-267 (1990)
4NBAC Report, pg. 14
5are separated soon after fertilization when the embryo consists of only two to
eight cells and then implanted into the uterus of separate surrogate \parents"
and allowed to develop normally in the womb. This form of cloning has great
relevance for the livestock breeding industry and is not a cause of the current
controversy.
Nuclear transplantation cloning is the most sophisticated cloning tech-
nique. It involves removing the nucleus from an egg and replacing it with a
nucleus taken from another cell. Once implanted in the egg, the embryo is al-
lowed to develop along its natural course. The ospring thereby created is a
genetic \twin" of the donor animal. Until recently, scientists believed that only
embryonic cells before reaching a certain stage of maturity could be utilized
as donor cells in this process. This is because it was believed that once the
embryonic cells began to dierentiate and become specialized, that is become
cells of specic types of tissue, they lost their totipotency. What the scientists
who created Dolly demonstrated was that the nucleus of a dierentiated adult
mammalian somatic cell could be reprogrammed and used in this process. In
other words, cell dierentiation and specialization can be reversed in the so-
matic cell of an adult mammal and a genetic twin of that animal can be created
from that cell. The process used is known as somatic cell nuclear transplan-
tation (SCNT). Of course the clone would still have to go through the normal
stages of development of its species so the two animals would not be present in
the same stage of development at any time, but for the rst time it is possible
to create a mammalian organism which is genetically identical to a pre-existing
6adult organism from the genetic material contained in a somatic cell of the adult
organism. This latter point is where the revolution lies.
In short, the procedure used by the scientists at the Roslin Institute
began by extracting a cell from an adult sheep's utter and then removing the
nucleus from the egg of another sheep. The donor sheep's cell nucleus and the
egg were then fused by exposure to an electrical current which also resulted in
activating the process of division within the new cell. The developing embryo
was then implanted within the womb of a third sheep and left to develop nor-
mally. A major drawback of the scientists technique was that only 1 of 277 of
their attempts at this process developed into a live lamb. This and the fact that
the method utilized had not allowed for absolute verication that the donor cell
used was a fully dierentiated cell, made some scientists wonder if perhaps a
less than fully dierentiated cell had been used in the experiment and thus that
the results were not as revolutionary as was being claimed.
Any doubts as to the possibility of cloning an adult mammal via the
method of nuclear transplantation was put to rest July 22, 1998 by a report out
of the University of Hawaii. Researchers there had documented proof that they
had not only successfully cloned adult mice, but that they had made clones of
the clones.5 These researchers reported that they had produced more than 50
identical cloned mice.6 They also noted a higher success rate than that achieved
by the scientists at the Roslin institute (about 3%).7 and attributed it to the
5University of Hawaii, UH News (press release date July 22, 1998)
<http://www.hawaii.edu/ur/News Releases?NR July98/cloning.html>
6Id.
7Id.
7fact that they utilized a slightly dierent technique which consisted of injecting
the nuclei from the cell of a donor mouse into the enucleated egg where division
was jump started using chemical, as opposed to electrical, processes with the
result then being implanted into the uterus of a surrogate \parent" for normal
fetal development.8
The experiments above indicate that there is nothing from a scientic
standpoint which would stop the cloning of an adult human being. Early ques-
tions focused on the fact that embryonic gene activation in sheep occurs later
than it does in humans and thus timing might be a limiting factor in the cloning
of humans. The concurrent period in mice however is much shorter than in hu-
mans so from the University of Hawaii study it appears that timing may not
inhibit eorts as much as had been speculated. If we can clone an adult human
being then, the question becomes one of the uses undertaking such an activity
could be put to.
B.
USES OF SCNT HUMAN CLONING TECHNOLOGY
As indicated above, nuclear transplant technology is not synonymous with
human cloning, but is merely a technique which may be used to accomplish
the latter. Short of actually cloning human beings, this technology holds great
promise for the medical and biotechnology industries as well as for the produc-
8Id.
8tion of livestock. \Work with [nuclear transplantation technology] is already pro-
viding unparalleled insights into fundamental biological processes and promises
to provide great practical benet in terms of improved livestock, improved means
of producing pharmaceutical proteins, and prospects for regeneration and repair
of human tissues."9
Notwithstanding the tremendous possibilities engendered by this new
technology in other areas though, we still need to examine the benets, if any,
related to the cloning of adult human beings by SCNT. The most often cited
and morally defensible application for this technology is in infertility programs.
In a variety of situations, these techniques may allow couples previously unable
to bare children to have children genetically related to the donor parent. Also,
for couples whose families carry a genetic disposition towards certain illnesses or
disabilities, the cloning of a healthy parent can allow for the birth of a healthy
child without the concurrent risks of developing the feared genetically induced
abnormalities. These and an assortment of other similar situations could result
in SCNT delivering great benets to families seeking to have children.
Beyond the aforementioned uses however, in and of themselves controversial
in some circles, the questions of moral defensibility of our actions become more
dicult to satisfy. Certain individuals have suggested programs or procedures
for cloning humans in order to harvest the clone's organs for transplantation into
genetically compatible non-clones. This practice could essentially eliminate the
possibility of organ rejection by the immune system of an organ recipient and
9NBAC Report, pg. 34
9also solve the current shortage of available organs for transplantation. Others
have imagined eugenic programs designed to eliminate or reduce the incidence
of some genetically induced disabilities. As described by its proponents, this
proposal is similar in spirit and practice to that described above involving par-
ents wishing to have a healthy child. The benets and harms of both courses of
action can be easily imagined.
Despite the concerns which may be raised by the above applications, any work
carried out in the eld of human cloning will shed great light on the processes
of human development and the role genetics plays in this development. Thus,
from a purely scientic standpoint, the new insights gained into the very nature
of life itself may be invaluable. This new knowledge, in turn, is likely to lead to
a new understanding of diseases and disabilities of many kinds and perhaps also
their cures. It may then be possible to control, if not eradicate altogether, many
of the health concerns which currently occupy the human species. Any program
which may result in the amelioration of human pain and suering caries with it
obvious benets and thus its implementation cannot be dismissed out of hand.
Given the uses and benets herein described, the next question which must be
considered is whether the cloning of human beings via SCNT technology should
be undertaken.
III.
THE DEBATE OVER HUMAN CLONING AND SCNT
TECHNOLOGY
10The debate over human cloning by application of SCNT technology is taking
place on many fronts. The consensus among scientists is that current methods
for cloning human beings using this technology pose too great a risk to the de-
veloping clone to justify attempting to carry out such a feat. Until more reliable
procedures are developed, human cloning by these means will result in babies
born with severe genetic abnormalities. The hazards to the developing fetus are
demonstrated by the low success rate of the above experiments and the fact that
the researchers who created Dolly also \generated dozens of fetuses with severe
malformations."10 Thus, the scientic community seems to favor a temporary
moratorium on such activities until such time as they can be demonstrated to
be reasonably benign.
In legal circles, much of the debate revolves around the idea of the act
of procreation as a constitutional right.11 This \right" was given rather expan-
sive treatment by the court for the Northern District of Illinois when it stated
that \within the cluster of constitutionally protected choices [is] the right to
submit to a medical procedure that may bring about...pregnancy" including the
decision to undergo in vitro fertilization using donated embryos.12 According
to University of Texas Law Professor John Robertson \[I]f procreative liberty
is taken seriously, a strong presumption in favor of using technologies that cen-
10Katheryn D. Katz, The Clonal Child: Procreative Liberty and Asexual Reproduction, 8
Alb. L.J. Sci. & Tech. 1, 28 (1997)
11See, e.g., Griswold v. Conneticut, 381 U.S. 379 (1965) (the right whether to bear children
is protected under the constitutional right to privacy); Eisenstadt v. Baird, 405 U.S. 438 (1972)
(the right whether to bear children is protected under the constitutional right to privacy)
12Lifchez v. Hartigan, 735 F.Supp. 1361, 1377 (N.D. Ill. 1990), a'd without opinion, sub
nom., Scholberg v. Lifchez, 914 F.2d 260 (7th Cir. 1990), cert. denied, 111 S.Ct. 787 (1991).
11trally implicate reproductive interests should be recognized. Although procre-
ative rights are not absolute, those who would limit procreative choice should
have the burden of establishing substantial harm."13 This, he argues, is the
traditional analysis engaged in in decisions regarding procreational freedoms.14
Robertson has gone on to argue that cloning specically should be included in
our bundle of procreative liberties because it is so similar to current forms of re-
production and family formation that it should be treated equivalently.15 Thus,
lacking some \substantial harm," it would seem that legal principles indicate a
permissive attitude towards the use of this new technology for cloning humans,
at least in the context of child rearing.
The moral/ethical arguments seem focused in three general areas. The
rst two deal with the aects of cloning on, and the well being of, the clones
themselves while the third deals with the overall eect on society that carrying
out this activity en mass would have. The initial area of concern regards the
treatment of clones as objects as opposed to as human beings. It is feared by
some that if people are allowed to produce clones at will, the resulting ospring
will be treated as possessions or objects instead of as living beings in possession
of basic human rights. This argument is especially relevant when the subject of
harvesting clones for their organs is discussed. The counter to this argument is
that individuals currently can have children at will and are more or less charged
with the responsibility to raise them as children. Still, the ability to create a
13John A. Robertson, Children of Choice: Freedom and the New Reproductive Technologies
40-41 (1994).
14Id.
15John A. Robertson, Liberty, Identity, and Human Cloning, 76 Tex. L. Rev. 1371, 1394
(1998)
12human being for the specic purpose of transplantation of their organs raises
serious questions about the liberty and well being of the person so created.
The next area of concern revolves around the attainment of an individual
identity by a clone. When the genetic make-up of a particular human being
can be reproduced exactly in ones ospring, there are questions as to whether
society or the clone herself will ever think of the clone as a unique individual.
The argument is made that given the outcome of the life of the individual donor
that the clone was based on, there will be a set of expectations as to what the
clone is capable of and indeed may eventually become. This set of expectations,
it is feared, may preclude the development of an independent self in the clone.
The strength of this argument is that it is based upon perception and not re-
ality. That is, although strict genetic determinism does not govern the type
of individual a person will become, the perception in peoples minds often does
not correspond to reality and may in fact contradict it, thus resulting in the
situation feared.
The nal scenario involves the use of eugenics to create some kind of a \master
race." While we all can agree that the elimination of human suering through
genetic engineering is a laudable goal, we must be careful as to how far we are
willing to go in \perfecting" our species. For instance, at what point does an
undesirable characteristic, such as being short, become a disability which we
would choose to eradicate. While it is easy to favor the elimination of diabetes,
where do we stop? How do we choose who is to be cloned and can we permit
ourselves to grant this freedom to some and not others? Moreover, when at-
13tempting to clone true for certain intangible characteristics such as intelligence,
we will become the slaves of our necessarily imperfect denitions. Disappoint-
ment will also follow when those who aren't aware discover that environmental
conditions throw a monkey wrench into the gears of genetic determinism and
that what they sought is not inevitably what they get.
Finally, in the area of religion, the argument most often put forth is that man
is putting himself in the sphere of God. It has been argued that by choosing to
create life in this manner, man is somehow committing a grave and dangerous
\sin". In this milieu, mans hubris is evidenced by his will to create human life by
\articial" means, and must be avoided by refusing the opportunity presented
to us. According to Gilbert Meilander, it is part of man's essential nature in
God's plan to be \begotten, not made."16 The counter to this argument is that
by practicing this new technology we are merely utilizing the tools that God
has given us by ordering nature in the manner that he has chosen. In so doing,
we exercise our rightful dominion over the Earth and its creatures, granted to
man by God in Genesis.17
This brief discussion certainly does not sum up all the arguments in the debate,
but it does give a good overview of those arguments most often enunciated.
While I do not oer an answer to any of these questions, they are presented so
that we may evaluate the proposal for FDA regulation of human cloning given
below. It will be important that any proposed regulation or legislation address
16Gilbert Meilander, Remarks on human cloning to the National Bioethics Advisory Com-
mission, March 13, 1997.
17Genesis 1:28 (New International Version Study Bible), \God blessed them and said to
them... ll the earth and subdue it. Rule over... every living creature that moves...."'
14the concerns of a vast cross section of the American public. As a result, we will
be revisiting these issues in the discussion which follows.
IV.
GOVERNMENTAL RESPONSE
In anticipation of the report of Dolly to be published in Nature, President
Clinton, on February 24, 1997, issued a directive to the National Bioethics
Advisory Commission (NBAC). In this directive the President requested that
the NBAC conduct a \thorough review of the legal and ethical issues associated
with the use of this technology" and make \recommendations on possible federal
actions to prevent it's abuse."18 A week later the President barred the use of
federal funds for any research leading to the cloning of human beings until there
was time to complete a review of its ethical implications.19 In the same address,
Clinton \asked for a voluntary moratorium on the cloning of human beings" to
be adhered to by the private sector.20
The NBAC released it's report June 6, 1997. In the report, the NBAC
concluded that \at this time it is morally unacceptable for anyone to attempt to
create a child using somatic cell nuclear transfer cloning...because...information
18Clinton Seeks Legal, Ethics Review of Issues Related to Human Cloning, BNA Chem.
Reg. Daily (Bur. of Nat'l. Aairs Inc.) February 26, 1997.
19Clinton Bars Federal Funding for Human Cloning; Seeks Voluntary Halt, BNA Chem.
Reg. Daily (Bur. of Nat'l. Aairs Inc.) March 6, 1997.
20Id.
15indicates [it] is not safe to use in humans at this time."21 Based on this and
other ndings the commission recommended:
1. \[C]ontinuation of the current moratorium on the use
of federal funding in support of any attempt to create a child by somatic cell
nuclear transfer."
2. A request be made for voluntary compliance with the morato-
rium by all non-federally funded research and commercial interests.
3. \Federal legislation should be enacted to prohibit anyone from
attempting...to create a child through somatic cell nuclear transfer cloning...[but
that] such legislation include a sunset clause."
4. \Any regulatory or legislative action undertaken to eect the
foregoing prohibition...should be carefully written so as not to interfere with
other important areas of scientic research."
5. If a ban is not enacted, or is ever lifted, clinical use of SCNT
techniques should be preceded by research trials governed by accepted protocols.
6. The U.S. should cooperate with other international eorts to
regulate human cloning.
7. Widespread and continuing deliberations on the issues involved
should be carried out as well as an eort to educate the lay public in the areas
of genetics and other biomedical sciences.22
Three days after the release of the commissions report, Clinton proposed the
Cloning Prohibition Act of 1997. The Act was designed to have the eect of
prohibiting for ve years the use of SCNT technology for the purpose of cloning
a human being. In order to insure that the Act didn't interfere with bene-
cial biomedical and agricultural activities, Clinton stressed that \this legisla-
tion...will not prohibit the use of [nuclear transplantation technology] to clone
DNA cells, and it will not ban the cloning of animals."23 Despite administration
eorts, the proposed legislation was never acted upon.
21NBAC Report pg. 108.
22Id. at 109-110.
23Clinton Proposes 5-Year Ban on Human Cloning, BNA Washington Insider (Bur. of
Nat'l. Aairs Inc.) June 10, 1997.
16Before Clinton proposed his legislation on human cloning, 16 bills were intro-
duced in 12 dierent state legislatures.24 One bill banned the use of government
funds for any research using cloned cells or tissues, two banned the use of gov-
ernment funds for cloning a complete human being, nine banned the cloning of
a human being regardless of whether funding was public or private, two banned
any research using cloned cells or tissue while two others could have had the
eect of unintentionally banning research using cloned cells or tissue.25 It is
clear that this patchwork of state legislation would not have created a consis-
tent regime for researchers and biotech companies to operate in. In fact, some
of the legislation prohibited practices already well established and accepted. If
these laws were to go into eect, many of the current medical techniques health
care workers and the public depend on would be forbidden.
One of the rst federal congressional proposals was H.R. 922, intro-
duced be Rep. Vernon Ehlers (R-Mich.) on March 15, 1997. The purpose of
this bill and it's companion H.R. 923, also proposed by Ehlers, is to prohibit the
use of federal funds to conduct or support research on the cloning of humans
using SCNT technology. While H.R. 922 was approved by the House Science
committee in July of 1997, it is still under consideration by the House Com-
24States with bills pending: banning the use of government funds for any research using
cloned cells or tissues: Alabama (A.B. 1082); banning the use of government funds for cloning
a complete human being: Missouri (1997 Mo. H.B. 824), Maryland (Md. H.J.R. 28); banning
the cloning of a human being regardless of whether funding was public or private: Alabama
(S.B. 511), California (Cal. S.B. 1344), Illinois (1997 Ill. H.B. 2235 | 5 and 1997 Ill. S.B.
1829), New Jersey (N.J.A.B. 2849 | 1), New York (1997 S.B. 2877), North Carolina (S.B.
782), Oregon (Ore. S.B. 1017 | 1) West Virginia (W.Va. S.B. 410); banning any research
using cloned cells or tissue: California (A.B. 1251), Florida (Fla. H.B. 1237); which could
have the eect of unintentionally banning research using cloned cells or tissue: South Carolina
(H.B. 3617 | 16-17-745(B), New York (A.B. 5383). See, NBAC Report pg. 104 for cite list.
25NBAC Report pg. 104.
17merce Committee where it was referred.26
Another early bill, S. 368, later amended and reintroduced as S. 1601
and sponsored by Sen. Christopher Bond (R-Mo.), had essentially the same pur-
pose as the House bill mentioned above. The nal bill is designed to prohibit any
person or entity from using SCNT technology for the purpose of cloning a human
as well as prohibiting importation of cloned embryos created by the same tech-
nology.27 According to the bill's summary, it was drafted with the intention of
protecting scientic research in mind.28 In a press release Bond commented that
\[H]uman cloning has no place in the world of legitimate scientic research,"
that mankind is \not prepared from an ethical or moral standpoint" for this
technology and that Congress had the responsibility of enacting \a permanent
ban on human cloning."29
Some of the same criticisms that had been expressed in relation to state
legislative proposals were echoed in response to the Bond bill. Of most con-
cern is that due to the broad and ill dened language found in the bill it pro-
hibits practices already well established and accepted and would have the eect
of prohibiting promising areas of research.30 The \assertions that it protects
biomedical research are ludicrous" said Sean Tipton of the American Society for
26Research Oversight: FDA May Assert Its Authority to Regulate Human Cloning Technol-
ogy Under Biologic Product Regs., The Blue Sheet (F-D-C- Reports, Inc.) Volume 41, Issue
2, January 14, 1998
27Lott Promises Vote on Cloning Ban Before Senate's President's Day Recess, BNA Wash-
ington Insider (Bur. of Nat'l. Aairs Inc.) February 4, 1998.
28Id.
29Senate Democrats Block Immediate Vote on Bond Bill to Ban Human Cloning, BNA
Washington Insider (Bur. of Nat'l. Aairs Inc.) February 6, 1998.
30FDA Arms Authority to Regulate Human Cloning Involving Nuclear Transfer, BNA
Washington Insider (Bur. of Nat'l Aairs Inc.) January 21, 1998.
18Reproductive Medicine (ASRM).31 The Biotechnology Industry Organization
(BIO) submitted a statement declaring that \biomedical research into deadly
and disabling diseases is far to important to rush to enact legislation [such as
the Bond bill] which would unequivocally undermine promising research and
therapies."32 Restrictions on research such as those found in this bill may pre-
vent possible cures for cancer, cystic brosis, heart disease, diabetes and other
disabling conditions.33
In response to these concerns, Senate Democrats submitted there own pro-
posal, S. 1602. This bill proposes a 10 year moratorium on human cloning
activities and contains much more precise language concerning the activities
aected. In addition, it would mandate that at the end of the 10 year mora-
torium, the issues involved would be revisited in order to evaluate whether a
new regulatory regime was indicated. This bill is much more responsive to the
concerns of industry, health care workers and academics and follows the rec-
ommendations issued by the NBAC. Sen. Dianne Feinstein (D-Calif.), one of
the sponsors of the bill, emphasized the \enormous harm" that would be done
by passage of an uninformed bill in this matter and urged congress to carefully
consider and seek a real understanding of the technical issues involved.34 To
date, neither of these Senate bills has been enacted.
31Sharon Schmickle, Capital Hill Struggles to Set Proper Limits on Science and Human
Ingenuity, Minneapolis Star Tribune, February 9, 1998.
32Id.
33Ethical Issues Deserve More Attention in Context of Cloning Legislation, Panel Told,
BNA Washington Insider (Bur. of Nat'l. Aairs Inc.) February 13, 1998.
34See, infra, note 29.
19V.
HUMAN CLONING AND FDA REGULATION
A.
EXISTING GUIDELINES
The FDA's involvement in this matter was triggered by the announcement
of Dr. Richard Seed, a physicist, on January 7, 1998, that he intended to begin
using SCNT technology to begin human cloning operations for sterile couples at
a Chicago clinic. As no regulation in this area was believed to exist at the time,
the announcement caused panic in many circles. Filling this apparent regula-
tory vacuum the FDA, in a statement issued a few days later, announced that
it had the authority to regulate cloning technology as a biological product.35
The acting FDA commissioner Michael Friedman made it clear that the FDA
was prepared to take all actions available to stop \unauthorized" human cloning
attempts.36
The agency claimed authority to regulate this activity under section
351 of the Public Health Services Act.37 According to agency and industry
35FDA Has Authority to Regulate Cloning Technology as Biologic Product, Agency States
After Chicago Physicist Seed Announces Plans For Human Cloning Clinic, Health News Daily
(F-D-C Reports, Inc.) Volume 10, Issue 8, January 13, 1998.
36News Services, No Human Cloning Without Approval, FDA Says, Minneapolis Star Tri-
bune, January 20, 1998.
3742 U.S.C. 262 et. seq. See eg., The Food and Drug Administration, Proposed Ap-
proach to Regulation of Cellular and Tissue-Based Products (last modied February 28, 1997)
<http://www.fda.gov/cber/cberftp.html> (Proposed Regs.)
20sources,38 regulatory framework for the regulation of cellular and tissue-based
products (RCTP) proposed in February of 1997 would give FDA the appropri-
ate tools to oversee the use and development of this new technology.39 These
regulations were initially proposed in an attempt to provide a unied framework
for the oversight of cellular and tissue-based products, replacing the fragmented
approach to these articles previously applied.40 One of the stated goals of the
RCTP was to ensure the clinical safety and eectiveness of tissues and cells
that are highly processed.41 It is clear however, that in drafting the regulations
proposed, the topic of human cloning had not been considered.
Agency ocials sought to bring human cloning by SCNT under the
rubric of the RCTP, through a clause in the proposed regulations which stated
that, \[C]ells or tissues that are more-than-minimally manipulated" would be
subject to the requirements of the regulations.42 According to industry sources,
\proposal[s] to clone humans using nuclear transfer technology [propose] much
more than minimal manipulation" of human cells.43 Further, based on the same
information given earlier, FDA has determined that the type of manipulations
involved in cloning a human being using SCNT technology poses \serious health
and safety issues" for the developing fetus and its mother.44 According to the
38FDA Asserts Authority to Regulate Human Cloning: An Out For Industry Wary of
Legislatve Ban?, The Pink Sheet (F-D-C Reports, Inc.) Volume 60, Issue 3, January 19, 1998;
Lisa Seachrist, BIO Says Human Cloning Falls Under FDA's Purview, BIOWORLD Today,
Vol. 9, No. 9, January 15, 1998.
39Proposed Approach to Regulation of Cellular and Tissue-Based Products, 62 Fed. Reg.
9721 (1997) (to be codied at 21 C.F.R. Chapter I); Proposed Regs. Infra at note 37.
40Proposed Regs. Infra. at note 37.
41Id.
42Id.
43See, Infra. note 38.
44Rick Weiss, Human Clone Research Will be Regulated; FDA Asserts it Has Authority to
Regulate Attempts at Human Cloning, The Washington Post, January 20, 1998.
21FDA then, these factors indicate that any individual wishing to attempt to
clone a human using SCNT technology would have to submit to the require-
ments mandated by the aforementioned regulations.
At rst, the formal procedures followed by these individuals would in-
clude having to le an \investigational new drug" application (IND).45 This
would include having to demonstrate that the procedure being planned does
not pose an unreasonable risk of harm to potential human subjects. In evalu-
ating an IND the agency would require pre-clinical data including any gained
from trial programs and models involving animals to ensure safety and ecacy.
Once safe methods have been demonstrated and accepted though, FDA would
seek to establish manufacturing and product standards ensuring safety and e-
cacy for industry wide application in SCNT cloning processes. Under this latter
regime, those wishing to clone a human being would be \subject to process-
ing controls that generally would cover chemistry, manufacturing and controls
(CMC's) and to premarket requirements for determination of safety and eec-
tiveness."46 Thus, once such standards have been established, those wishing to
engage in the practice of human cloning would presumably have to adhere to
standards for combing a somatic cell with an egg for the purpose of creating a
human clone and for the content or makeup of the product of these two entities
itself.
B.
45Washington Post Infra. at note 44; Proposed Regs. Infra. at note 37.
46Proposed Regs. Infra. at note 36.
22ANALYSIS OF REGULATION UNDER EXISTING GUIDELINES
As an interim measure, FDA's proposal to regulate human cloning technol-
ogy under the cellular and tissue-based based products regulations is exactly
what the situation calls for. Great urgency was infused into the quest to enact
some kind of regulatory scheme by Dr. Seed's announcement. In addition, most
legislative proposals advanced seem plagued by a lack of knowledge of many of
the issues involved. By lling the regulatory void, FDA not only brings unifor-
mity to this area, but insures that lawmakers no longer have to worry about
the prospects of immediate unconstrained activity in the area of human cloning.
After all, given the current development in the eld, it is highly improbable that
safety and ecacy could be demonstrated in the near future, making approval
of any IND application unlikely for some time. FDA's announcement therefore,
achieved two short term goals. First, it guaranteed that at a minimum, public
health and safety concerns would not be neglected in a rush to institute this new
technology. Second, it gave lawmakers a chance to slow down, better educate
themselves on the matters under consideration and engage in a more informed
analysis before demanding enactment of any new congressional edicts.
Industry has demonstrated widespread support for this interim ap-
proach. Carl Feldbaum, president of BIO, stated that the approach gave law-
makers \breathing space" to consider responsible legislation while at the same
time protecting biomedical research.47 A spokesman for the Pharmaceutical Re-
47See, Infra. note 38.
23search Manufacturers Association (PhRMA) commented that \lawmakers are
moving too fast."48 This is an \area that needs much more debate than the
senate has had to date" and FDA has the \ expertise to look at the immediate
concerns."49 Support in academia is strong as well. According to a statement
from the Association of American Medical Colleges (AAMC) a \self imposed
ve year moratorium on human cloning coupled with [FDA] oversight should
eectively safeguard the public while fostering medical progress."50 Even those
in favor of a perpetual ban on human cloning activities could save their strength
for the battle which lay ahead since any authorized short term cloning activities
were highly improbable.
Taken as a whole, the regulatory framework proposed by FDA would
address many of the long term issues raised in the debate discussed earlier as
well. As mentioned in preceding paragraphs, it would at a minimum require
that the safety and ecacy of any cloning procedure be demonstrated before
any human clone was allowed to be created using SCNT methods, thereby al-
laying public health concerns. The proposed framework would not, however,
foreclose the possibility of future application of the technology. Thus, if at some
point in the future the technology were to become highly enough rened, it could
be made available. In addition, Friedman has stressed FDA's commitment to
\balance" in the regulation of this technology so that research and development
won't be unnecessarily inhibited.51 By requiring safety in application without
48See, infra. note 29.
49See, infra. note 31.
50GOP Bill Banning Human Cloning Put On Hold as Lawmakers Struggle With Legislation,
Transplant News (Information Access Co.) Vol. 8, No. 3, February 13, 1998.
51Human Cloning Subject to FDA Jurisdiction as a Biological Product Agency Says, The
24interfering with legitimate research while also creating a regulatory pathway for
potential future approval, this scheme would address many of the fears enunci-
ated by the scientic, regulatory and health care communities, including those
in industry.
The RCTP also provides a balancing mechanism to be used when con-
templating constitutional considerations. Counter to Professor Robertson's sug-
gestion that the burden of proof be placed on those who oppose the availabil-
ity of cloning technology to prove harm, the proposed regulations require the
aforementioned showing of safety on the part of those who would utilize the
technology. Despite this fact, once shown to be safe, it appears that this avenue
of procreation would be made available to any who could aord it. At that
point, this \constitutional freedom" would be as available as other currently
used fertility methods. The legal burden imposed would simply mitigate in fa-
vor of public health concerns and, some would argue, the constitutional liberties
of the developing fetus. Under this analysis, it appears that at least the main
theme, if not the particular details, of Robertson's argument for a weighing of
factors in order to preserve liberties is retained and that SCNT cloning of hu-
man beings would be permitted lacking \substantial harm."
As for addressing moral/ethical concerns the current regulatory pro-
posal is not quite as strong. In it's present form, it would seem the only argument
the agency could make aecting the nal use of the clone would be based on
safety and health concerns of the clone itself. By arguing that, harvesting clones,
Gray Sheet (F-D-C Reports Inc.) Vol. 24, Is. 3, January 19, 1998.
25either for their organs for transplantation into others or to create some type of
permanent \labor" or other such class, inherently endangers the health of the
clone, the agency might be able to require those producing clones to prove that
these clones are not being manufactured for such purposes before such facilities
are licensed. While this seems to be the strongest weapon in the Agency's arse-
nal along this front, the success this argument would enjoy is unknown. Along
the same lines, this regulatory scheme doesn't even touch upon the religious
concerns expressed. In order to make up for these deciencies Agency ocials
have suggested public hearings on the issue of human cloning.52 According to
these ocials the hearings would \be done in the open [so that] everyone has a
say and we face our fears in public and discuss them."53
While hearings would certainly be a necessary step towards implemen-
tation of FDA's plans for long term application of these regulation to SCNT
human cloning technology, they are not enough to save the proposal. It is
of paramount importance to remember that when these regulations had been
proposed, the idea of cloning an adult human was still in the realm of science
ction. Thus they were fashioned without many of the concerns now being ex-
pressed considered at all. While on research and development fronts the process
of human cloning can in it's technological features be easily analogized to the
other biotechnologies covered by these regulations, along the moral/ethical and
religious fronts the comparison is woefully inadequate. These moral/ethical and
religious questions cannot be answered in a lab.
52See, Infra. note 44.
53Id.
26To many, this new capability impacts on the very meaning of our hu-
manity. Before unquestioned authority to regulate this technology is handed
over to the FDA, the democratic process, as it operates through the peoples
representatives in Congress, should specically consider all the implications of
any proposed regulatory regime. As a result, while the FDA's proposal is an
excellent short term solution, and it's eect on many of the issues considered
is quite desirable, the fact that many other important concerns have not been,
and cannot appropriately be, addressed by the Agency indicates that a new
regulatory regime might be necessitated.
C.
FRAMEWORK FOR A NEW PROPOSAL
A favorable feature of any type of federal regulation in this area is that it
would supply uniform standards to follow throughout the country. This uni-
formity \would relieve the need to rely on the cooperation of diverse medical
and scientic societies, or the actions of diverse [institutional review boards], to
achieve [policy objectives]"54 and would facilitate researchers in their attempts
to clearly identify the demarcation lines of permitted activities. Despite the
diminution in reliance upon such sources to achieve policy objectives, by in-
stituting a federally mandated regime, medical and scientic societies would
also become strengthened and unied in this area and so be better able to lend
their well informed voice to the nation in advising where lines should be drawn
54NBAC Report.
27and the advantages of this technology to all individuals. Additionaly, it would
facilitate the development of interstate commerce in this area prevent \forum
shopping" brought on by competition between the states designed to attract
this type of industry by enacting weak, if any, regulation regarding the use of
this technology. Such competition would be dangerous since this technology, as
stated above, is open to seriously questionable uses.
For the short term, regulation in this area should be left in the hands of the
FDA. This should be considered purely an interim measure until Congress has
considered and passed new legislation. In arriving at this legislation, Congress
should conduct open hearings on the issues involved allowing widespread partic-
ipation. The hearings should be informed by the NBAC report as it was arrived
at through the free exchange of ideas by individuals from a vast array specialties
covering religion, science, industry and government. Beyond this, the following
framework provides a starting point for discussion.
MODEL LEGISLATION FOR THE REGULATION OF HUMAN CLONING
(1) All attempts to clone a human being using somatic cell nuclear
transplantation techniques shall be governed by this statute.
(a) The term \Human being" shall refer only to individuals, freely
functional or not, existing outside the womb.
(b) Any and all fetal or embryonic research or other issues concern-
ing treatment of a fetus or embryo, will be covered by laws already composed
for those purposes.
(2) Any individual, entity or institution desiring to engage in hu-
man cloning activities must obtain a license for such from the Food and Drug
Administration (FDA).
(3) In regulating the human cloning process, the FDA will treat it as
involving \more than minimally manipulated" cells and thus needing to satisfy
28all the requirement prescribed for such entities under it's Cellular and Tissue-
Based Products regulations. This will include initially the need to undergo the
IND application process and the demonstration that any proposed methods of
producing an embryo are eective and safe for both the developing fetus and
the mother in which the embryo is to be implanted. Once it becomes possible to
establish industry wide standards, FDA will establish processing controls and
other pre-birth requirements for determination of safety and eectiveness.
(a) The FDA may, from time to time and as it sees t, prescribe
any additional requirements for the issuance of such a license as long as such
requirements do not contradict the requirements set forth in this section or any
other section dealing with the regulation of human fetal or embryonic research
and treatment.
(b) In addition to the requirements stated above and any additional
requirements established by the FDA, in order to obtain and/or keep a license
the individual, entity or institution in question must;
(i) Demonstrate that they intend to engage in cloning activities for
the sole purpose of assisting people to have children, intended to be reared as
children with the full compliment of human rights accorded other non-cloned
individuals;
(ii) Demonstrate their individual prociency in the use of somatic
cell nuclear transfer technology for the purpose of cloning a human;
(iii) Demonstrate compliance with all rules, regulations and laws
concerning research and treatment of the human fetus and embryo;
(iv) File complete records of each such attempt which must include
whether such attempt was a success or failure, the actual product of said at-
tempt, the identity of the DNA donor and the identity of the clones designated
parents;
(v) Abide by any and all other regulations governing the practice
of reproductive medicine.
(4) Any research directed at the cloning of a human being using
somatic cell nuclear transplantation must be done with the goal of producing
healthy children for rearing.
(a) Any research conducted using human beings or their embryos
must conform to accepted human medical trial protocols.
(b) A human being CANNOT be cloned simply for the sake of pure
research.
(5) It will be a crime carrying up to years of imprisonment and
up to a dollar ne to commit or attempt to commit any of the following
acts;
(a) Engage in the practice of human cloning without obtaining, and
complying with all requirements for obtaining, a license;
(b) Knowingly violate any of the rules or regulations authorized
under this section;
(c) Perform, participate in or aid in any material way the act of
cloning a human being when the individual in question knows or has reason to
29know that either the care giver, the donor or the respective parents of the clone
are engaging in this activity
(i) for the eugenic purpose of race selection;
(ii) for the purpose of harvesting the organs of the clone for trans-
plantation into another individual;
(iii)
for the creation of a human being in a lab outside of a human womb.
This proposal is meant only to be a starting point. I have great condence
in FDA's ability to regulate in this area but realize that there are other well
reasoned positions. In particular, this proposal is not likely to satisfy those
who oppose cloning on religious or certain other moral grounds. I have tried to
compromise in order to include as many interests and objections as possible. I
hope that it may be helpful.
VI. CONCLUSION
Given the current state of human cloning technology using somatic cell nu-
clear transfer techniques, it is likely to be quite some time before a clone of a
fully formed, freely function human being can be created. Nonetheless, given
the claims by certain individuals that they will begin attempting to put this
technology to use in the near future, some immediate government oversight is
necessary. In the short term, the FDA can regulate this activity under its pro-
posed regulations on cellular and tissue-based products. This seems a very good
interim approach. In the long run though, while FDA may be the appropriate
30entity to administer any regulatory regime, Congress is going to have to face the
issue head on and determine what the appropriate framework is. SCNT human
cloning technology holds great promise for mankind, but is also accompanied by
grave concerns. By addressing these issues in a careful and thoughtful manner
now, we hold open the promise this technology holds for us in the future.
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